Genetic susceptibility to multiple sclerosis: Brain structure and cognitive function in the general population

Background: Multiple sclerosis (MS) affects brain structure and cognitive function and has a heritable component. Over a 100 common genetic risk variants have been identified, but most carriers do not develop MS. For other neurodegenerative diseases, risk variants have effects outside patient populations, but this remains uninvestigated for MS. Objectives: To study the effect of MS-associated genetic variants on brain structure and cognitive function in the general population. Methods: We studied middle-aged and elderly individuals (mean age = 65.7 years) from the population-based Rotterdam Study. We determined 107 MS variants and additionally created a risk score combining all variants. Magnetic resonance imaging (N = 4710) was performed to obtain measures of brain macrostructure, white matter microstructure, and gray matter voxel-based morphometry. A cognitive test battery (N = 7556) was used to test a variety of cognitive domains. Results: The MS risk score was associated with smaller gray matter volume over the whole brain (βstandardized = −0.016; p = 0.044), but region-specific analyses did not survive multiple testing correction. Similarly, no significant associations with brain structure were observed for individual variants. For cognition, rs2283792 was significantly associated with poorer memory (β = −0.064; p = 3.4 × 10−5). Conclusion: Increased genetic susceptibility to MS may affect brain structure and cognition in persons without disease, pointing to a “hidden burden” of MS.

[1]  A. Hofman,et al.  The Rotterdam Scan Study: design update 2016 and main findings , 2015, European Journal of Epidemiology.

[2]  Alexander Teumer,et al.  No Association Between Polygenic Risk for Schizophrenia and Brain Volume in the General Population , 2015, Biological Psychiatry.

[3]  A. Hofman,et al.  Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia , 2015, Alzheimer's & Dementia.

[4]  A. Alcina,et al.  Genome-wide significant association with seven novel multiple sclerosis risk loci , 2015, Journal of Medical Genetics.

[5]  Todd M. Solomon,et al.  The unite study: Understanding chronic traumatic encephalopathy through clinico-pathological correlation — methods and instructive cases , 2015, Alzheimer's & Dementia.

[6]  Clifford R. Jack,et al.  Association of Alzheimer's disease GWAS loci with MRI markers of brain aging , 2015, Neurobiology of Aging.

[7]  Wiro J. Niessen,et al.  Tract-specific white matter degeneration in aging: The Rotterdam Study , 2015, Alzheimer's & Dementia.

[8]  Benjamin F. J. Verhaaren,et al.  TMEM106B Influences Volume of Left-Sided Temporal Lobe and Interhemispheric Structures in the General Population , 2014, Biological Psychiatry.

[9]  Wiro J Niessen,et al.  Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy , 2014, Human brain mapping.

[10]  M. Carrington,et al.  Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects , 2013, PLoS genetics.

[11]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[12]  J. Buizer-Voskamp,et al.  Genetic Schizophrenia Risk Variants Jointly Modulate Total Brain and White Matter Volume , 2013, Biological Psychiatry.

[13]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[14]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[15]  P. D. de Bakker,et al.  Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci , 2011, Annals of neurology.

[16]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[17]  William S Bush,et al.  Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. , 2010, American journal of human genetics.

[18]  Wiro J. Niessen,et al.  Brain tissue volumes in relation to cognitive function and risk of dementia , 2010, Neurobiology of Aging.

[19]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[20]  Wiro J. Niessen,et al.  White matter lesion extension to automatic brain tissue segmentation on MRI , 2009, NeuroImage.

[21]  Frederik Barkhof,et al.  Regional DTI differences in multiple sclerosis patients , 2009, NeuroImage.

[22]  D. Auer,et al.  Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. , 2009, Brain : a journal of neurology.

[23]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.

[24]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[25]  F. Paul,et al.  Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.

[26]  A. Verma,et al.  Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study , 2008 .

[27]  Wiro J. Niessen,et al.  Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification , 2007, NeuroImage.

[28]  R. Benedict,et al.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.

[29]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[30]  R. Bakshi,et al.  Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[31]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[32]  G J Barker,et al.  The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.

[33]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[34]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.

[35]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.